Pfizer and BioNTech announced early positive update from German phase 1/2 COVID-19 vaccine study
On Jul. 20, 2020, BioNTech and Pfizer announced initial data from their ongoing German Phase 1/2, open-label, non-randomized,…
On Jul. 20, 2020, BioNTech and Pfizer announced initial data from their ongoing German Phase 1/2, open-label, non-randomized,…
On Jul. 13, 2020, Pfizer and BioNTech announced that two of the companiesメ four investigational vaccine candidates from…
On Jul. 6, 2020, the European Investment Bank (EIB) and CureVac announced they had entered into a $75…
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
On Jun. 17, 2020, CureVac announced that the German Health Authority Paul-Ehrlich-Institute and the Belgian Federal Agency for…
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
On Jun. 15, 2020, the German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp,…
On Jun. 13, 2020, AstraZeneca announced an agreement with Europeメs Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France,…
On Jun. 1, 2020, U.S. Dept. of Defense announced it had begun an effort to collect 8,000 donated…
On May 26, 2020, researchers at the Max Planck Institute for Evolutionary Anthropology in Germany and the Karolinska…
On May 13, 2020, Immunic announced it had received first regulatory approval from Germany’s BfArM to initiate a…
On May 5, 2020, Pfizer and BioNTech announced the first participants have been dosed in the U.S. in…
On Apr. 23, 2020, CHF Solutions announced that it had shipped the first commercial orders of its next…
On Apr. 22, 2020, BioNTech and Pfizer announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…
On Apr. 17, 2020, after promising COVID-19 treatments in Germany, France, Italy, Spain and the U.S,, ExThera Medical’s…
On Apr. 9, 2020, Pfizer and BioNTech disclosed additional details of their collaboration to advance candidates from BioNTech’s…
On Mar. 31, 2020, Chembio Diagnostics announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test…
On Mar. 30, 2020, Bayer announced it had made available more than 40 virus diagnostics devices from its…
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…
On Mar. 17, 2020, Pfizer and BioNTech SE announced the companies have agreed to a letter of intent…
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…
On Mar. 5, 2020, Hologic announced a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on…
On Dec. 31, 2019, Ege T. Kavalali, Ph.D., professor and acting chair of the Department of Pharmacology in…
On Jul. 9, 2019, Vanderbilt Vaccine Center announced that Director James Crow Jr., MD, had been awarded half…
On Apr. 13, 2003, the International Human Genome Sequencing Consortium announced the completion of the Human Genome Project…
On Nov. 14, 2012, scientists from the U.S., United Kingdom and Germany announced they had completed the first…
On Jun. 13, 2012, in a project led by the Max Planck Institute for Evolutionary Anthropology in Leipzig,…
On Feb. 7, 2012, The Max Planck Institute for Evolutionary Anthropology, in Leipzig, Germany, completed the genome sequence…
On Oct. 13, 2011, an international team, led by researchers at McMaster University and the University of Tubingen…
On Aug. 30, 2011, Amnis, a Seattle-based manufacturer of advanced cell imaging systems, announced the company had been…